Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cytotherapy|June 1, 2022
Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cellsMariane Cariati Tirapelle, Ana Luiza Oliveira Lomba, Renata Nacasaki Silvestre, et al.Methods in Molecular Biology (Clifton, N.J.)|May 22, 2025
Engineered CAR-NK Cells for Cancer Immunotherapy: Lentiviral-Based CAR Transduction of NK-92 CellsDayane Schmidt, Mariane Cariati Tirapelle, Sima Ebrahimabadi, et al.Immunotherapy Advances|August 3, 2022
Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapyDayane Schmidt, Sima Ebrahimabadi, Kauan Ribeiro de Sena Gomes, et al.Behavioural Brain Research|April 16, 2021
Role of 5-HT<sub>1A</sub> receptors in the ventral hippocampus in the regulation of anxiety- and panic-related defensive behaviors in ratsPaloma Molina Hernandes, Matheus Fitipaldi Batistela, Heloísa Helena Vilela-Costa, et al.Frontiers in Immunology|December 29, 2025
2B4 co-stimulation and dasatinib modulation enhance anti-CD19 CAR-NK-92 cell cytotoxicityMatheus Henrique Dos Santos, Júlia Teixeira Cottas de Azevedo, Mara Elisama da Silva Januário, et al.Frontiers in Immunology|October 11, 2023
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect <i>in vivo</i>Renata Nacasaki Silvestre, Jiri Eitler, Julia Teixeira Cottas de Azevedo, et al.Cytotherapy|July 6, 2024
IL-27-engineered CAR.19-NK-92 cells exhibit enhanced therapeutic efficacyAlison Felipe Bordini Biggi, Renata Nacasaki Silvestre, Mariane Cariati Tirapelle, et al.Pageof 1